Mitsuyoshi Namba

Summary

Affiliation: Hyogo College of Medicine
Country: Japan

Publications

  1. doi request reprint New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
    Mitsuyoshi Namba
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Hyogo 663 8501, Japan
    Clin Exp Nephrol 17:10-5. 2013
  2. ncbi request reprint Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin
    Yoshiki Kusunoki
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663 8501, Japan
    Endocr J 60:431-9. 2013
  3. ncbi request reprint Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes
    Masaru Tokuda
    Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663 8501, Japan
    Endocr J 61:365-72. 2014
  4. pmc Incretin responses to oral glucose load in Japanese non-obese healthy subjects
    Etsuko Nagai
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1, Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Diabetes Ther 2:20-8. 2011
  5. doi request reprint Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring
    Yoshiki Kusunoki
    Division of Diabetes Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1, Mukogawa cho, Nishinomiya, Hyogo 663 8501, Japan Electronic address
    Diabetes Res Clin Pract 108:342-9. 2015
  6. pmc Very short-term effects of the dipeptidyl peptidase-4 inhibitor sitagliptin on the secretion of insulin, glucagon, and incretin hormones in Japanese patients with type 2 diabetes mellitus: analysis of meal tolerance test data
    Kazuki Murai
    Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1, Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Drugs R D 14:301-8. 2014
  7. doi request reprint Response of incretins (GIP and GLP-1) to an oral glucose load in female and male subjects with normal glucose tolerance
    Toshihiro Matsuo
    Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Japan Electronic address
    Diabetes Res Clin Pract 106:e25-9. 2014
  8. pmc Medium-term effects of insulin degludec on patients with type 1 diabetes mellitus
    Rie Nakae
    Division of Diabetes, Endocrinology, and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Drugs R D 14:133-8. 2014
  9. ncbi request reprint Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus
    Tomoyuki Katsuno
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663 8501, Japan
    Endocr J 60:733-42. 2013
  10. ncbi request reprint Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus
    Etsuko Nagai
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan
    Endocr J 58:869-77. 2011

Collaborators

  • Tomoyuki Katsuno
  • Yoshiki Kusunoki
  • Etsuko Nagai
  • Jun ichiro Miyagawa
  • Kazuki Murai
  • Masayuki Miuchi
  • Masaru Tokuda
  • Toshihiro Matsuo
  • Tomoya Hamaguchi
  • Takafumi Akagami
  • Fumihiro Ochi
  • Rie Nakae
  • Hiroyuki Konya
  • Takashi Ikawa
  • Kana Miyakoshi
  • Kahori Satani
  • Akira Suehiro
  • Yoshikazu Hasegawa
  • Tetsuya Ishikawa
  • Eizo Kakishita
  • Kousuke Kohri
  • Akiko Umehara

Detail Information

Publications12

  1. doi request reprint New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
    Mitsuyoshi Namba
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Hyogo 663 8501, Japan
    Clin Exp Nephrol 17:10-5. 2013
    ..Indications and/or contraindications for incretin-based therapy should be clarified by prospectively studying the experiences of Japanese T2DM patients undergoing this therapy in the clinical setting...
  2. ncbi request reprint Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin
    Yoshiki Kusunoki
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663 8501, Japan
    Endocr J 60:431-9. 2013
    ..The beneficial effects may also protect the endocrine pancreas and inhibit body weight gain...
  3. ncbi request reprint Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes
    Masaru Tokuda
    Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663 8501, Japan
    Endocr J 61:365-72. 2014
    ..These findings suggest that a more marked improvement in metabolic parameters by exenatide can be partly dependent on the manifestation of gastrointestinal symptoms...
  4. pmc Incretin responses to oral glucose load in Japanese non-obese healthy subjects
    Etsuko Nagai
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1, Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Diabetes Ther 2:20-8. 2011
    ....
  5. doi request reprint Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring
    Yoshiki Kusunoki
    Division of Diabetes Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1, Mukogawa cho, Nishinomiya, Hyogo 663 8501, Japan Electronic address
    Diabetes Res Clin Pract 108:342-9. 2015
    ....
  6. pmc Very short-term effects of the dipeptidyl peptidase-4 inhibitor sitagliptin on the secretion of insulin, glucagon, and incretin hormones in Japanese patients with type 2 diabetes mellitus: analysis of meal tolerance test data
    Kazuki Murai
    Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1, Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Drugs R D 14:301-8. 2014
    ..To assess its antidiabetic potency, we used meal tolerance tests (MTTs) to determine the very short-term effects of sitagliptin on plasma concentrations of insulin and glucagon...
  7. doi request reprint Response of incretins (GIP and GLP-1) to an oral glucose load in female and male subjects with normal glucose tolerance
    Toshihiro Matsuo
    Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Japan Electronic address
    Diabetes Res Clin Pract 106:e25-9. 2014
    ..We first reported that plasma glucose and GIP levels were higher in males during the early phase of the OGTT...
  8. pmc Medium-term effects of insulin degludec on patients with type 1 diabetes mellitus
    Rie Nakae
    Division of Diabetes, Endocrinology, and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1 1 Mukogawa cho, Nishinomiya, Hyogo, 663 8501, Japan
    Drugs R D 14:133-8. 2014
    ....
  9. ncbi request reprint Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus
    Tomoyuki Katsuno
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663 8501, Japan
    Endocr J 60:733-42. 2013
    ..The results of this investigation confirmed that add-on therapy with sitagliptin to various insulin regimens could improve glycemic control without severe hypoglycemia and/or weight gain...
  10. ncbi request reprint Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus
    Etsuko Nagai
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan
    Endocr J 58:869-77. 2011
    ..MTT findings suggest that this combination therapy improves blood glucose control by delaying carbohydrate absorption and modifying the responses of incretins, GIP, and GLP-1...
  11. doi request reprint Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus
    Hiroyuki Konya
    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663 8501, Japan
    Metabolism 59:1294-9. 2010
    ..Taken together, the results show that gliclazide may be more useful for the prevention of diabetic vascular complications than glibenclamide...
  12. ncbi request reprint [Incretin-based therapy in patients with type 1 diabetes mellitus]
    Jun ichiro Miyagawa
    Division of Diabetes and Metabolism, Internal Medicine, Hyogo College of Medicine
    Nihon Rinsho 69:923-9. 2011
    ..Taken together, incretin-based therapy may be worth testing in patients with type 1 diabetes...